ALXN

Alexion Pharmaceuticals, Inc. News Headlines

$183.11
*  
1.79
0.97%
Get ALXN Alerts
*Delayed - data as of Feb. 26, 2015  -  Find a broker to begin trading ALXN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALXN Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Pharmacyclics Could Very Well Be The Next Alexion Pharmaceuticals
2/23/2015 10:52:00 AM - Seeking Alpha


Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2014 Update
2/21/2015 4:37:00 PM - Seeking Alpha


My Top Biotechnology Stocks For 2015
2/19/2015 9:49:00 AM - Seeking Alpha


Alexion Pharmaceuticals To Participate In Leerink Swann Conference At 1:50 PM ET
2/12/2015 12:50:00 PM - RTT News


Biotech Stocks: What's Hot, What's Not - As Seen By Market-Makers, Their Clients
2/11/2015 12:37:00 PM - Seeking Alpha


Gilead, Amgen Q4 Earnings And Weak Outlook Affect Biotech ETFs
2/6/2015 7:17:00 AM - Seeking Alpha


Post-Earnings, Alexion Is Financed Heading Into Q1 Regulatory Catalysts
2/3/2015 8:06:00 PM - Seeking Alpha


Update: Alexion Q4 Earnings
2/3/2015 10:06:00 AM - Seeking Alpha


Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
1/30/2015 4:00:00 PM - Seeking Alpha


Alexion Pharmaceuticals Promotes COO to CEO Post
1/29/2015 5:30:00 PM - Dow Jones Business News


Alexion Pharmaceuticals Q4 14 Earnings Conference Call At 10:00 AM ET
1/29/2015 9:03:00 AM - RTT News


Alexion Pharma Turns To Profit In Q4; Names David Hallal CEO - Quick Facts
1/29/2015 6:44:00 AM - RTT News


Playing Chemocentryx Against Alexion: Opportunity For Asymmetric Return
1/28/2015 3:10:00 PM - Seeking Alpha


Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog
1/28/2015 10:00:00 AM - Investopedia


Gilead Includes Pan-Genotypic Agent in HCV Licensing Deals - Analyst Blog
1/27/2015 6:55:00 AM - Investopedia


The Medicines Co. Gets CHMP Recommendation for 3 Drugs - Analyst Blog
1/27/2015 6:30:00 AM - Investopedia


Will Alexion's (ALXN) Soliris Drive Q4 Earnings Beat? - Analyst Blog
1/27/2015 3:20:00 AM - Investopedia


What Lessons Has Express Scripts Taught Us? The Future For The Pharmaceutical Industry
1/23/2015 7:30:00 AM - Seeking Alpha


Minerva Neurosciences Gains on Positive Data on MIN-202 - Analyst Blog
1/23/2015 5:20:00 AM - Investopedia


Sanofi's Cerdelga Cleared in the EU for Gaucher Disease - Analyst Blog
1/23/2015 4:00:00 AM - Investopedia


S&P 500 Q4 Review: Utilities And Health Care Were The Top Sectors In 2014
1/22/2015 5:48:00 PM - Seeking Alpha


BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog
1/22/2015 6:00:00 AM - Investopedia


Illumina Launches MiSeq FGx for Forensic DNA Analysis - Analyst Blog
1/22/2015 5:50:00 AM - Investopedia


Endo Prices $1.2B Senior Notes Offering for Auxilium Deal - Analyst Blog
1/22/2015 5:10:00 AM - Investopedia


Keryx to Raise $110 Million Through Issuance of Shares - Analyst Blog
1/22/2015 4:10:00 AM - Investopedia